These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4024041)

  • 1. The influence of a new low molecular weight sulphated polysaccharide from mussel broth (Org 30016) on haemostasis.
    Bergqvist D; Frohm B; Stenberg P; Nilsson IM
    Thromb Res; 1985 May; 38(3):233-42. PubMed ID: 4024041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel semi-synthetic sulphated polysaccharide with potent antithrombin activity.
    Nilsson IM; Rothman U; Stenberg P; Frohm B; Persson NH
    Br J Haematol; 1982 Feb; 50(2):335-43. PubMed ID: 7059522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate.
    Ofosu FA; Blajchman MA; Modi GJ; Smith LM; Buchanan MR; Hirsh J
    Br J Haematol; 1985 Aug; 60(4):695-704. PubMed ID: 2411283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of heparin fragments of different molecular weights on experimental thrombosis and haemostasis.
    Bergqvist D; Nilsson B; Hedner U; Pedersen PC; Ostergaard PB
    Thromb Res; 1985 Jun; 38(6):589-601. PubMed ID: 4024047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of anticoagulant effects of some sulphated polysaccharides.
    Andersson LO; Hoffman J; Holmer E; Larm O; Larsson K; Söderström G
    Thromb Res; 1982 Dec; 28(6):741-7. PubMed ID: 6132465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sulphated polysaccharide--the effects in vivo and in vitro on the haemostatic system in healthy volunteers.
    Bergqvist D; Nilsson IM
    Thromb Res; 1981 Aug; 23(3):309-15. PubMed ID: 7302931
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of low molecular weight heparin on experimental thrombosis and haemostasis--the influence of production method.
    Ostergaard PB; Nilsson B; Bergqvist D; Hedner U; Pedersen PC
    Thromb Res; 1987 Mar; 45(6):739-49. PubMed ID: 3590101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant activities of a pentosane polysulphate: comparison with standard heparin and a fraction of low molecular weight heparin.
    Soria C; Soria J; Ryckewaert JJ; Holmer E; Caen JP
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):455-63. PubMed ID: 6160640
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonist.
    Buchanan MR; Brister SJ
    Thromb Res; 2000 Sep; 99(6):603-12. PubMed ID: 10974347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the antithrombotic and haemorrhagic effects of low molecular weight heparin fractions: the influence of the method of preparation.
    Cade JF; Buchanan MR; Boneu B; Ockelford P; Cater CJ; Cerskus AL; Hirsh J
    Thromb Res; 1984 Sep; 35(6):613-25. PubMed ID: 6506020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin and its low molecular weight derivatives: anticoagulant and antithrombotic properties.
    Holmer E; Söderberg K; Bergqvist D; Lindahl U
    Haemostasis; 1986; 16 Suppl 2():1-7. PubMed ID: 3744129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of low molecular weight heparin in combination with dihydroergotamine on experimental thrombosis and haemostasis.
    Bergqvist D; Nilsson B
    Thromb Haemost; 1987 Oct; 58(3):893-5. PubMed ID: 2829377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant and antithrombotic effects of chemically modified heparins and pentosanpolysulfate.
    Krupinski K; Breddin HK; Casu B
    Haemostasis; 1990; 20(2):81-92. PubMed ID: 1693353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits.
    Holmer E; Mattsson C; Nilsson S
    Thromb Res; 1982 Mar; 25(6):475-85. PubMed ID: 7112507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the different mechanisms by which heparin and polysulphated xylan (PZ 68) inhibit blood coagulation in man.
    Ryde M; Eriksson H; Tangen O
    Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):435-45. PubMed ID: 6172879
    [No Abstract]   [Full Text] [Related]  

  • 17. Haemostasis in the microvasculature of the rabbit mesentery, effects of some pharmacological agents of current interest in haemostasis and thrombosis.
    Bergqvist D; Arfors KE
    Haemostasis; 1976; 5(2):74-84. PubMed ID: 950177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis.
    Sinha U; Ku P; Malinowski J; Zhu BY; Scarborough RM; Marlowe CK; Wong PW; Lin PH; Hollenbach SJ
    Eur J Pharmacol; 2000 Apr; 395(1):51-9. PubMed ID: 10781674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulant effects of a low molecular weight heparinoid (Org 10172) in human volunteers and haemodialysis patients.
    ten Cate H; Henny CP; ten Cate JW; Büller HR; Mooy MC; Surachno S; Wilmink JM
    Thromb Res; 1985 Jul; 39(2):211-22. PubMed ID: 3161213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.
    Olson ST; Swanson R; Raub-Segall E; Bedsted T; Sadri M; Petitou M; Hérault JP; Herbert JM; Björk I
    Thromb Haemost; 2004 Nov; 92(5):929-39. PubMed ID: 15543318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.